Evidence map›Paper›PMID 29339421›Full record

Trial reportBioscience reports2018

Licheng Wang, Yanliang Tang, Ye Chen

Open access · goldAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Bioscience reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Screening of potential key ferroptosis-related genes in Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2023
    Article
  4. Article
  5. Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.American journal of respiratory and critical care medicine · 2020
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Licheng WangDepartment of Intensive Care Unit, Fuyang Hospital of Traditional Chinese Medicine, 4 Guihua Road, Fuyang District, Hangzhou, Zhejiang, China.
Yanliang TangDepartment of Intensive Care Unit, Fuyang Hospital of Traditional Chinese Medicine, 4 Guihua Road, Fuyang District, Hangzhou, Zhejiang, China.
Ye ChenDepartment of Pneumology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China chenyemed@sina.com.
Zhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term poor airflow. Recently, variants in the hypoxia inducible factor 1α (

Indexed as

Asian PeopleModels, GeneticPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveAgedCase-Control StudiesChinaHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiddle AgedRisk FactorsHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitCOPDHIF1Asingle nucleotide polymorphism

Identifiers

PMID29339421
PMCPMC5843754
OpenAlexW2783603149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.